Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients
Status:
Suspended
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The main objective of this study is to assess the effect of spironolactone on interstitial
fibrosis in kidney transplant recipients receiving calcineurin inhibitors